Clin2
NCT06910111Possibly a fitNot yet recruiting

Capturing heart health with a fat-blocking supplement

Atherosclerotic Disease

Part of Heart & circulation clinical trials.

This study tests a natural supplement (polyglucosamine) that may help reduce fat absorption, aiming to prevent heart disease and stroke. It is for people with high blood pressure, diabetes, or high cholesterol who also have early signs of artery thickening.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
240 people
Ages
45 years to 65 years
Study type
Interventional

Who can take part

  • You are between 45 and 65 years old.
  • Your body mass index (BMI) is between 26 and 35.
  • You have high blood pressure, type 2 diabetes, or high cholesterol, and have been on stable medication for at least 6 months.
  • Your carotid artery (neck artery) wall thickness is greater than 1.00 mm (measured by ultrasound).
  • You are not taking certain medications like GLP-1 agonists, fosinopril, or acarbose, and you are not allergic to shellfish.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07515573Not yet recruiting
Heart Health Supplement Study for People at Low Risk

This study tests whether a supplement called Cardiol Forte can help improve cholesterol and blood sugar levels in people who have slightly elevated cholesterol but are at low risk for heart disease. Researchers want to see if this supplement can naturally help manage cholesterol without prescription drugs.

Bologna, BO
NCT06647108Not yet recruiting
Food supplement for metabolic syndrome

This study tests a dietary supplement designed for people with metabolic syndrome. It aims to see if the supplement can help improve key markers of metabolic health, like blood sugar and cholesterol levels.

Bologna, Bologna
NCT06810466Recruiting
Dietary supplements for mild high cholesterol

This study tests two dietary supplements to see if they can improve cholesterol levels in people with mildly high cholesterol who are otherwise healthy and at low risk for heart disease.

Bologna, Italy
NCT07000357Recruiting· Phase 3
Study of AZD0780 to reduce heart attack and stroke risk

This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.

Athens, Alabama
NCT07034690Recruiting· Phase 4
Better cholesterol control for high-risk patients

This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.

Abu Dhabi
NCT05117424Recruiting
Study of metabolism and plaque changes in heart disease

This trial looks at how treating or managing conditions like diabetes, prediabetes, obesity, kidney disease, or high cholesterol affects artery plaque over time. It may help researchers find ways to slow plaque buildup and related heart risks.

Shanghai

Hear when a new Atherosclerotic Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.